{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,26]],"date-time":"2024-07-26T04:31:12Z","timestamp":1721968272556},"reference-count":73,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2010,8,1]],"date-time":"2010-08-01T00:00:00Z","timestamp":1280620800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Bone"],"published-print":{"date-parts":[[2010,8]]},"DOI":"10.1016\/j.bone.2010.05.006","type":"journal-article","created":{"date-parts":[[2010,5,17]],"date-time":"2010-05-17T02:24:10Z","timestamp":1274063050000},"page":"341-352","source":"Crossref","is-referenced-by-count":13,"title":["Basal bone phenotype and increased anabolic responses to intermittent parathyroid hormone in healthy male COX-2 knockout mice"],"prefix":"10.1016","volume":"47","author":[{"given":"Manshan","family":"Xu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shilpa","family":"Choudhary","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olga","family":"Voznesensky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qi","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Douglas","family":"Adams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vilmaris","family":"Diaz-Doran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qian","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Goltzman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lawrence G.","family":"Raisz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carol C.","family":"Pilbeam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bone.2010.05.006_bib1","series-title":"Principles of bone biology","first-page":"1235","article-title":"Prostaglandins and bone metabolism","author":"Pilbeam","year":"2008"},{"key":"10.1016\/j.bone.2010.05.006_bib2","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/BF00666095","article-title":"Regulation of prostaglandin synthase-1 and prostaglandin synthase-2","volume":"13","author":"Herschman","year":"1994","journal-title":"Cancer Metastasis Rev."},{"key":"10.1016\/j.bone.2010.05.006_bib3","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1146\/annurev.biochem.69.1.145","article-title":"Cyclooxygenases: structural, cellular, and molecular biology","volume":"69","author":"Smith","year":"2000","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.bone.2010.05.006_bib4","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0090-6980(02)00024-2","article-title":"Cyclooxygenase isozymes and their gene structures and expression","volume":"68\u201369","author":"Tanabe","year":"2002","journal-title":"Prostaglandins Other Lipid Mediat."},{"key":"10.1016\/j.bone.2010.05.006_bib5","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1172\/JCI8195","article-title":"Prostaglandin G\/H synthase-2 is required for maximal formation of osteoclast-like cells in culture","volume":"105","author":"Okada","year":"2000","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bone.2010.05.006_bib6","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1359\/jbmr.2003.18.10.1813","article-title":"Extracellular calcium is a potent inducer of cyclooxygenase-2 in murine osteoblasts through an ERK signaling pathway","volume":"18","author":"Choudhary","year":"2003","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2010.05.006_bib7","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.bone.2007.03.009","article-title":"Cyclooxygenase-2 gene disruption promotes proliferation of murine calvarial osteoblasts in vitro","volume":"41","author":"Xu","year":"2007","journal-title":"Bone"},{"key":"10.1016\/j.bone.2010.05.006_bib8","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1210\/endo-86-6-1436","article-title":"Prostaglandins: stimulation of bone resorption in tissue culture","volume":"86","author":"Klein","year":"1970","journal-title":"Endocrinology"},{"key":"10.1016\/j.bone.2010.05.006_bib9","series-title":"Bone and mineral research, annual 2","first-page":"286","article-title":"Prostaglandins in bone and mineral metabolism","author":"Raisz","year":"1983"},{"key":"10.1016\/j.bone.2010.05.006_bib10","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1006\/bbrc.1998.8610","article-title":"Osteoclast differentiation factor mediates an essential signal for bone resorption induced by 1 alpha, 25-dihydroxyvitamin D3, prostaglandin E2, or parathyroid hormone in the microenvironment of bone","volume":"246","author":"Tsukii","year":"1998","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bone.2010.05.006_bib11","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.4049\/jimmunol.172.4.2504","article-title":"Suppression of osteoprotegerin expression by prostaglandin E2 is crucially involved in lipopolysaccharide-induced osteoclast formation","volume":"172","author":"Suda","year":"2004","journal-title":"J. Immunol."},{"key":"10.1016\/j.bone.2010.05.006_bib12","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1210\/en.130.1.443","article-title":"Stimulation of bone nodule formation in vitro by prostaglandins E1 and E2","volume":"130","author":"Flanagan","year":"1992","journal-title":"Endocrinology"},{"key":"10.1016\/j.bone.2010.05.006_bib13","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1002\/jbmr.5650100320","article-title":"Bone marrow cells are targets for the anabolic actions of prostaglandin E2 on bone: induction of a transition from nonadherent to adherent osteoblast precursors","volume":"10","author":"Scutt","year":"1995","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2010.05.006_bib14","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/(SICI)1097-4644(19990401)73:1<36::AID-JCB5>3.0.CO;2-F","article-title":"Prostaglandin E2 stimulates the formation of mineralized bone nodules by a cAMP-independent mechanism in the culture of adult rat calvarial osteoblasts","volume":"73","author":"Kaneki","year":"1999","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.bone.2010.05.006_bib15","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S8756-3282(97)00033-1","article-title":"Systemic administration of an anabolic dose of PGE2 in young rats increases the osteogenic capacity of bone marrow","volume":"20","author":"Weinreb","year":"1997","journal-title":"Bone"},{"key":"10.1016\/j.bone.2010.05.006_bib16","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1172\/JCI0215681","article-title":"Cyclooxygenase-2 regulates mesenchymal cell differentiation into the osteoblast lineage and is critically involved in bone repair","volume":"109","author":"Zhang","year":"2002","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bone.2010.05.006_bib17","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1359\/jbmr.070321","article-title":"Strontium ranelate promotes osteoblastic differentiation and mineralization of murine bone marrow stromal cells: involvement of prostaglandins","volume":"22","author":"Choudhary","year":"2007","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2010.05.006_bib18","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.bbrc.2008.05.050","article-title":"Anabolic effects of PTH in cyclooxygenase-2 knockout osteoblasts in vitro","volume":"372","author":"Choudhary","year":"2008","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bone.2010.05.006_bib19","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1359\/jbmr.2005.20.10.1887","article-title":"Bone morphogenetic protein 2 induces cyclooxygenase 2 in osteoblasts via a Cbfa1 binding site: role in effects of bone morphogenetic protein 2 in vitro and in vivo. 2002","volume":"20","author":"Chikazu","year":"2005","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2010.05.006_bib20","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/8756-3282(94)90272-0","article-title":"Effects of prostaglandin E2 and risedronate administration on cancellous bone in older female rats","volume":"15","author":"Lin","year":"1994","journal-title":"Bone"},{"key":"10.1016\/j.bone.2010.05.006_bib21","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S8756-3282(97)00147-6","article-title":"The in vivo anabolic actions of prostaglandins in bone","volume":"21","author":"Jee","year":"1997","journal-title":"Bone"},{"key":"10.1016\/j.bone.2010.05.006_bib22","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1677\/joe.0.1560051","article-title":"Differential effects of systemic prostaglandin E2 on bone mass in rat long bones and calvariae","volume":"156","author":"Suponitzky","year":"1998","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.bone.2010.05.006_bib23","doi-asserted-by":"crossref","first-page":"489","DOI":"10.3109\/15513819609168686","article-title":"Prostaglandin E1-induced hyperostosis: clinicopathologic correlations and possible pathogenetic mechanisms","volume":"16","author":"Faye-Petersen","year":"1996","journal-title":"Pediatr. Pathol. Lab. Med."},{"key":"10.1016\/j.bone.2010.05.006_bib24","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/S0022-3476(80)80282-4","article-title":"Cortical hyperostosis following long-term administration of prostaglandin E1 in infants with cyanotic congenital heart disease","volume":"97","author":"Ueda","year":"1980","journal-title":"J. Pediatr."},{"key":"10.1016\/j.bone.2010.05.006_bib25","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/BF02556354","article-title":"Systemic effects of prostaglandin E2 on vertebral trabecular remodeling in beagles used in a healing study","volume":"42","author":"Norrdin","year":"1988","journal-title":"Calcif. Tissue Int."},{"key":"10.1016\/j.bone.2010.05.006_bib26","doi-asserted-by":"crossref","first-page":"4580","DOI":"10.1073\/pnas.062053399","article-title":"Stimulation of bone formation and prevention of bone loss by prostaglandin E EP4 receptor activation","volume":"99","author":"Yoshida","year":"2002","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"10.1016\/j.bone.2010.05.006_bib27","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1359\/jbmr.2002.17.6.963","article-title":"Cyclooxygenase 2 function is essential for bone fracture healing","volume":"17","author":"Simon","year":"2002","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2010.05.006_bib28","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/ar607","article-title":"Cox-2: where are we in 2003?\u2014The role of cyclooxygenase-2 in bone repair","volume":"5","author":"Einhorn","year":"2003","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.bone.2010.05.006_bib29","doi-asserted-by":"crossref","first-page":"116","DOI":"10.2106\/00004623-200401000-00017","article-title":"Effect of COX-2-specific inhibition on fracture-healing in the rat femur","volume":"86-A","author":"Brown","year":"2004","journal-title":"J. Bone Joint Surg. Am."},{"key":"10.1016\/j.bone.2010.05.006_bib30","doi-asserted-by":"crossref","first-page":"114","DOI":"10.2106\/JBJS.F.00495","article-title":"Selective and nonselective cyclooxygenase-2 inhibitors and experimental fracture-healing. Reversibility of effects after short-term treatment","volume":"89","author":"Gerstenfeld","year":"2007","journal-title":"J. Bone Joint Surg. Am."},{"key":"10.1016\/j.bone.2010.05.006_bib31","doi-asserted-by":"crossref","first-page":"500","DOI":"10.2106\/JBJS.F.00127","article-title":"Dose and time-dependent effects of cyclooxygenase-2 inhibition on fracture-healing","volume":"89","author":"Simon","year":"2007","journal-title":"J. Bone Joint Surg. Am."},{"key":"10.1016\/j.bone.2010.05.006_bib32","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1007\/BF02556658","article-title":"Indomethacin modulation of load-related stimulation of new bone formation in vivo","volume":"45","author":"Pead","year":"1989","journal-title":"Calcif. Tissue Int."},{"key":"10.1016\/j.bone.2010.05.006_bib33","doi-asserted-by":"crossref","first-page":"S369","DOI":"10.1002\/jbmr.5650071403","article-title":"Control of bone architecture by functional load bearing","volume":"7","author":"Lanyon","year":"1992","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2010.05.006_bib34","first-page":"E287","article-title":"Indomethacin has distinct early and late actions on bone formation induced by mechanical stimulation","volume":"267","author":"Chow","year":"1994","journal-title":"Amer. J. Physiol."},{"key":"10.1016\/j.bone.2010.05.006_bib35","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.cytogfr.2006.01.005","article-title":"Regulation of bone biology by prostaglandin endoperoxide H synthases (PGHS): a rose by any other name","volume":"17","author":"Li","year":"2006","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.bone.2010.05.006_bib36","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1359\/JBMR.041124","article-title":"Mechanotransduction in bone does not require a functional cyclooxygenase-2 (COX-2) gene","volume":"20","author":"Alam","year":"2005","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2010.05.006_bib37","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/0092-8674(95)90125-6","article-title":"Prostaglandin synthase 2 gene disruption causes severe renal pathology in the mouse","volume":"83","author":"Morham","year":"1995","journal-title":"Cell"},{"key":"10.1016\/j.bone.2010.05.006_bib38","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1046\/j.1523-1755.2000.00413.x","article-title":"Postnatal development and progression of renal dysplasia in cyclooxygenase-2 null mice","volume":"58","author":"Norwood","year":"2000","journal-title":"Kidney Int."},{"key":"10.1016\/j.bone.2010.05.006_bib39","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1210\/en.2004-0734","article-title":"Do cyclooxygenase knockout mice have primary hyperparathyroidism?","volume":"146","author":"Xu","year":"2005","journal-title":"Endocrinology"},{"key":"10.1016\/j.bone.2010.05.006_bib40","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0092-8674(00)80402-X","article-title":"Multiple female reproductive failures in cyclooxygenase 2-deficient mice","volume":"91","author":"Lim","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.bone.2010.05.006_bib41","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1002\/jbmr.5650020617","article-title":"Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee","volume":"2","author":"Parfitt","year":"1987","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2010.05.006_bib42","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1002\/jbmr.5650051010","article-title":"Frequency distributions of tetracycline-based measurements: implications for the interpretation of bone formation indices in the absence of double-labeled surfaces","volume":"5","author":"Foldes","year":"1990","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2010.05.006_bib43","doi-asserted-by":"crossref","first-page":"10649","DOI":"10.1074\/jbc.M312203200","article-title":"Rescue of female infertility from the loss of cyclooxygenase-2 by compensatory up-regulation of cyclooxygenase-1 is a function of genetic makeup","volume":"279","author":"Wang","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bone.2010.05.006_bib44","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/S8756-3282(03)00057-7","article-title":"Anabolic action of parathyroid hormone on cortical and cancellous bone differs between axial and appendicular skeletal sites in mice","volume":"32","author":"Zhou","year":"2003","journal-title":"Bone"},{"key":"10.1016\/j.bone.2010.05.006_bib45","doi-asserted-by":"crossref","first-page":"5427","DOI":"10.1210\/en.138.12.5427","article-title":"Proto-oncogene c-fos is transcriptionally regulated by parathyroid hormone (PTH) and PTH-related protein in a cyclic adenosine monophosphate-dependent manner in osteoblastic cells","volume":"138","author":"McCauley","year":"1997","journal-title":"Endocrinology"},{"key":"10.1016\/j.bone.2010.05.006_bib46","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1007\/s00223-004-0239-1","article-title":"Parathyroid hormone induces receptor activity modifying protein-3 (RAMP3) expression primarily via 3\u2032, 5\u2032-cyclic adenosine monophosphate signaling in osteoblasts","volume":"77","author":"Phelps","year":"2005","journal-title":"Calcif. Tissue Int."},{"key":"10.1016\/j.bone.2010.05.006_bib47","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1210\/en.2007-0826","article-title":"CBP\/P300-interacting protein CITED1 modulates PTH regulation of osteoblastic differentiation","volume":"49","author":"Yang","year":"2008","journal-title":"Endocrinology"},{"key":"10.1016\/j.bone.2010.05.006_bib48","doi-asserted-by":"crossref","first-page":"4577","DOI":"10.1210\/en.2005-0239","article-title":"Chronic elevation of parathyroid hormone in mice reduces expression of sclerostin by osteocytes: a novel mechanism for hormonal control of osteoblastogenesis","volume":"146","author":"Bellido","year":"2005","journal-title":"Endocrinology"},{"key":"10.1016\/j.bone.2010.05.006_bib49","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.bone.2005.03.018","article-title":"SOST is a target gene for PTH in bone","volume":"37","author":"Keller","year":"2005","journal-title":"Bone"},{"key":"10.1016\/j.bone.2010.05.006_bib50","first-page":"358","article-title":"Downregulation of SOST\/sclerostin by PTH: a novel mechanism of hormonal control of bone formation mediated by osteocytes","volume":"6","author":"Bellido","year":"2006","journal-title":"J. Musculoskelet. Neuronal Interact."},{"key":"10.1016\/j.bone.2010.05.006_bib51","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1359\/jbmr.2002.17.9.1570","article-title":"Insulin-like growth factor I is required for the anabolic actions of parathyroid hormone on mouse bone","volume":"17","author":"Bikle","year":"2002","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2010.05.006_bib52","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1196\/annals.1346.043","article-title":"Mechanisms involved in skeletal anabolic therapies","volume":"1068","author":"Martin","year":"2006","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.bone.2010.05.006_bib53","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1073\/pnas.031573498","article-title":"Failure of ductus arteriosus closure and remodeling in neonatal mice deficient in cyclooxygenase-1 and cyclooxygenase-2","volume":"98","author":"Loftin","year":"2001","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"10.1016\/j.bone.2010.05.006_bib54","doi-asserted-by":"crossref","first-page":"22378","DOI":"10.1074\/jbc.270.38.22378","article-title":"A natural disruption of the secretory group II phospholipase A2 gene in inbred mouse strains","volume":"270","author":"Kennedy","year":"1995","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bone.2010.05.006_bib55","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/j.bone.2006.05.015","article-title":"The isozyme-specific effects of cyclooxygenase-deficiency on bone in mice","volume":"39","author":"Myers","year":"2006","journal-title":"Bone"},{"key":"10.1016\/j.bone.2010.05.006_bib56","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1385\/EP:15:1:29","article-title":"Cox-2 expression in the oxyphilic cells of the normal, hyperplastic, and adenomatous parathyroid gland","volume":"15","author":"Bell","year":"2004","journal-title":"Endocr. Pathol."},{"key":"10.1016\/j.bone.2010.05.006_bib57","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1210\/endo-109-5-1545","article-title":"Effects of prostaglandins on adenosine 3\u2032, 5\u2032-monophosphate content and adenylate cyclase activity in dispersed bovine parathyroid cells","volume":"109","author":"Gardner","year":"1981","journal-title":"Endocrinology"},{"key":"10.1016\/j.bone.2010.05.006_bib58","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/0090-6980(85)90149-2","article-title":"Production of prostaglandins by dispersed cells and fragments from bovine parathyroid glands","volume":"29","author":"Brown","year":"1985","journal-title":"Prostaglandins"},{"key":"10.1016\/j.bone.2010.05.006_bib59","doi-asserted-by":"crossref","first-page":"4641","DOI":"10.1210\/jc.2002-021404","article-title":"Normocalcemic primary hyperparathyroidism: evidence for a generalized target-tissue resistance to parathyroid hormone","volume":"88","author":"Maruani","year":"2003","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bone.2010.05.006_bib60","doi-asserted-by":"crossref","first-page":"3001","DOI":"10.1210\/jc.2006-2802","article-title":"Normocalcemic primary hyperparathyroidism: further characterization of a new clinical phenotype","volume":"92","author":"Lowe","year":"2007","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bone.2010.05.006_bib61","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/1043-6618(90)90744-X","article-title":"Effect of aspirin and indomethacin on the serum and urinary calcium, magnesium and phosphate","volume":"22","author":"Gomaa","year":"1990","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.bone.2010.05.006_bib62","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/S0009-9236(01)78384-1","article-title":"Pathogenetic role of cyclooxygenase-2 in hyperprostaglandin E syndrome\/antenatal Bartter syndrome: therapeutic use of the cyclooxygenase-2 inhibitor nimesulide","volume":"70","author":"Nusing","year":"2001","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.bone.2010.05.006_bib63","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1254\/jphs.FPJ05008X","article-title":"Comparative effects of indomethacin and nabumetone on urine and electrolyte output in conscious rats","volume":"99","author":"bin Long","year":"2005","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.bone.2010.05.006_bib64","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/S8756-3282(02)00683-X","article-title":"Effects of prostaglandin E2 on gene expression in primary osteoblastic cells from prostaglandin receptor knockout mice","volume":"30","author":"Li","year":"2002","journal-title":"Bone"},{"key":"10.1016\/j.bone.2010.05.006_bib65","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1038\/nature05883","article-title":"Prostaglandin E2 regulates vertebrate haematopoietic stem cell homeostasis","volume":"447","author":"North","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.bone.2010.05.006_bib66","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.bone.2006.04.006","article-title":"Alteration of femoral bone morphology and density in COX-2\u2212\/\u2212 mice","volume":"39","author":"Robertson","year":"2006","journal-title":"Bone"},{"key":"10.1016\/j.bone.2010.05.006_bib67","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/s00223-002-0009-x","article-title":"Congenital lack of COX-2 affects mechanical and geometric properties of bone in mice","volume":"73","author":"Chen","year":"2003","journal-title":"Calcif. Tissue Int."},{"key":"10.1016\/j.bone.2010.05.006_bib68","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1172\/JCI10523","article-title":"Primary hyperparathyroidism caused by parathyroid-targeted overexpression of cyclin D1 in transgenic mice","volume":"107","author":"Imanishi","year":"2001","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bone.2010.05.006_bib69","doi-asserted-by":"crossref","first-page":"5435","DOI":"10.1210\/en.137.12.5435","article-title":"Parathyroid hormone induces prostaglandin G\/H synthase-2 expression by a cyclic adenosine 3\u2032, 5\u2032-monophosphate-mediated pathway in the murine osteoblastic cell line MC3T3\u2013E1","volume":"137","author":"Tetradis","year":"1996","journal-title":"Endocrinology"},{"key":"10.1016\/j.bone.2010.05.006_bib70","doi-asserted-by":"crossref","first-page":"3594","DOI":"10.1210\/en.138.9.3594","article-title":"Parathyroid hormone increases prostaglandin G\/H synthase-2 transcription by a cyclic adenosine 3\u2032,5\u2032-monophosphate-mediated pathway in murine osteoblastic MC3T3-E1 cells","volume":"138","author":"Tetradis","year":"1997","journal-title":"Endocrinology"},{"key":"10.1016\/j.bone.2010.05.006_bib71","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/S8756-3282(02)00804-9","article-title":"Regulation of receptor activator of nuclear factor-kappa B ligand and osteoprotegerin mRNA expression by parathyroid hormone is predominantly mediated by the protein kinase A pathway in murine bone marrow cultures","volume":"31","author":"Lee","year":"2002","journal-title":"Bone"},{"key":"10.1016\/j.bone.2010.05.006_bib72","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/j.bone.2007.02.001","article-title":"Contributions of parathyroid hormone (PTH)\/PTH-related peptide receptor signaling pathways to the anabolic effect of PTH on bone","volume":"40","author":"Yang","year":"2007","journal-title":"Bone"},{"key":"10.1016\/j.bone.2010.05.006_bib73","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1359\/jbmr.2002.17.8.1430","article-title":"Bone morphogenetic protein 2 induces cyclooxygenase 2 in osteoblasts via a Cbfal binding site: role in effects of bone morphogenetic protein 2 in vitro and in vivo","volume":"17","author":"Chikazu","year":"2002","journal-title":"J. Bone Miner. Res."}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328210011981?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328210011981?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,10]],"date-time":"2018-12-10T23:53:35Z","timestamp":1544486015000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S8756328210011981"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,8]]},"references-count":73,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,8]]}},"alternative-id":["S8756328210011981"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2010.05.006","relation":{},"ISSN":["8756-3282"],"issn-type":[{"value":"8756-3282","type":"print"}],"subject":[],"published":{"date-parts":[[2010,8]]}}}